The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial (Q28287742)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial |
scientific article |
Statements
The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial (English)
Andreas Seekamp
Erwin Dhondt
Michael Diefenbeck
Ignace Demeyer
Guy Vundelinckx
Norbert Haas
Ulrich Schaechinger
Laura Wolowicka
Stefan Rammelt
Jan Stroobants
Ingo Marzi
Ansgar M Brambrink
Piotr Dziurdzik
Jacek Gasiorowski
Heinz Redl
Michael Beckert
Jasmin Khan-Boluki